Ensuring Continuity in Rare Disease Clinical Trials During the COVID-19 Crisis
With the COVID-19 crisis upon us, ensuring the smooth and proper running of Rare Disease clinical trials has become a significant challenge. Ergomed’s experts will share their insights into how they have adapted and are continuing to provide reliable and uninterrupted services for their clients, keeping the patient’s safety and well-being as the central focus.